Investigation Overview
December 6, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Ambit Biosciences Corp (NASDAQ:AMBI) shares over potential securities laws violations by Ambit Biosciences and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the s...
You must register (for free) or login to view the entire investigation.